Rapport Therapeutics Inc.... (RAPP)

9.06

1.91 (26.71%)

At close: Mar 04, 2025, 1:08 PM

Rapport Therapeutics Common Stock Cash Flow Statement

Table Mode

Year	FY23	FY22
Net Income	-34.79M	-10.65M
Depreciation & Amortization	112K	15K
Stock-Based Compensation	3.52M	n/a
Other Working Capital	1.8M	1.49M
Other Non-Cash Items	1.32M	5.94M
Deferred Income Tax	n/a	n/a
Change in Working Capital	2.65M	1.49M
Operating Cash Flow	-27.18M	-3.24M
Capital Expenditures	-1.64M	-284K
Acquisitions	n/a	n/a
Purchase of Investments	-77.22M	n/a
Sales Maturities Of Investments	n/a	n/a
Other Investing Acitivies	n/a	-5M
Investing Cash Flow	-78.86M	-5.28M
Debt Repayment	n/a	7.9M
Common Stock Repurchased	-4K	n/a
Dividend Paid	n/a	n/a
Other Financial Acitivies	145.09M	n/a
Financial Cash Flow	145.14M	39.69M
Net Cash Flow	39.09M	31.16M
Free Cash Flow	-28.82M	-3.53M